SBIR/STTR Research Award
SBIR Phase I: Sublancin 168 for Bacillus Spores Detection, Inactivation and Decontamination
Award amount
$97,928Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- SUN BIOMEDICAL TECHNOLOGIES
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
This Small Business Innovation Research (SBIR) Phase I project proposes to develop methods to use Sublancin 168 for detection, inactivation and decontamination of Bacillus spores.
The commercial application of this project will be in the area of detection and control of Bacillus anthracis, the causative agent of anthrax.
Technology keywords
Not reported